IV delivery places the administered dose into systemic circulation, but that does not mean 100% enters target cells, remains intact, reaches a specific organ, or produces a clinical benefit
Clin Pharmacokinet 58(9):12051214 Calvarysky B, Dotan I, Shepshelovich D, Leader A, Cohen TD (2024) Drug-drug interactions between glucagon-like peptide 1 receptor agonists and oral medications: a systematic review
Hyperglycemia or Hypoglycemia with Changes in Insulin Regimen: Changes in an insulin regimen (e.g., insulin strength, manufacturer, type, injection site or method of administration) may affect glycemic control and predispose to hypoglycemia or hyperglycemia
Saxenda is taken at a higher dose and approved for weight loss
This process enhances cellular health and improves the bodys detoxification pathways by binding harmful substances and facilitating their elimination
The FDA has specifically flagged risks including dosing errors, variable concentrations, improper storage during shipping, quality control differences, limited adverse-event reporting, and products falsely marketed for research or non-human-use purposes